Get the Stockscreener App
155.58
3.02%
4.3333
Inspire Medical Systems Inc stock is traded at $155.58, with a volume of 225.72K.
It is up +3.02% in the last 24 hours and up +5.61% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
See More
Previous Close:
$151.25
Open:
$154.5
24h Volume:
225.72K
Relative Volume:
0.46
Market Cap:
$4.68B
Revenue:
$802.80M
Net Income/Loss:
$53.51M
P/E Ratio:
89.93
EPS:
1.73
Net Cash Flow:
$91.12M
1W Performance:
-1.84%
1M Performance:
+5.61%
6M Performance:
-18.31%
1Y Performance:
-7.16%
1-Day Range:
$153.09
$158.75
1-Week Range:
$133.32
$163.35
52-Week Range:
$123.00
$225.00
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
155.58 | 4.68B | 802.80M | 53.51M | 91.12M | 1.73 |
|
ABT
Abbott Laboratories
|
132.04 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.63 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.36 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.58 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.50 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
3 Healthcare Stocks to Keep an Eye On - Yahoo Finance
Inspire Medical Systems, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 20, 2024 to Discuss Your RightsINSP - ACCESS Newswire
Lost Money on Inspire Medical Systems, Inc.(INSP)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Inspire Medical Systems, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationINSP - ACCESS Newswire
Investors Who Lost Money on Inspire Medical Systems, Inc. (INSP) Should Contact Levi & Korsinsky About Pending Class Action – INSP - ACCESS Newswire
Inspire medical systems outlines full launch of Inspire V with 17%-19% 2025 revenue growth target - MSN
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
Inspire Medical Systems, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Yahoo Finance
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts - MSN
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy - Yahoo Finance
Inspire Medical Systems (INSP) Target Price Lowered by Morgan St - GuruFocus
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know - Yahoo Finance
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2025 Earnings Call Transcript - Insider Monkey
Breaking Down Inspire Medical Systems: 13 Analysts Share Their Views - Benzinga
INSP's Q1 Revenue Surpasses Expectations with Strong Growth | IN - GuruFocus
Inspire Medical to fully launch next-gen system in U.S. this month - MassDevice
JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Med - GuruFocus
Inspire Medical Systems (INSP) Target Price Lowered by Morgan Stanley | INSP Stock News - GuruFocus
JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus
Inspire Medical Systems (INSP) Price Target Lowered by Wells Fargo | INSP Stock News - GuruFocus
Inspire Medical (INSP) Faces Price Target Reduction Amid Mid-Yea - GuruFocus
Inspire Medical (INSP): Morgan Stanley Updates Price Target Amid - GuruFocus
Inspire Medical (INSP): Morgan Stanley Updates Price Target Amidst Positive Outlook | INSP Stock News - GuruFocus
Inspire Medical Systems (INSP) Target Price Raised by Baird | IN - GuruFocus
Inspire Medical (INSP) Price Target Increased by Baird | INSP St - GuruFocus
Inspire Medical (INSP) Price Target Increased by Baird | INSP Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Inspire Medical Systems to $200 From $220, Keeps Overweight Rating - marketscreener.com
Inspire Medical Systems’ revenue up 23% to USD 201.3M in Q1 2025 - Medical Buyer
Inspire Medical Systems Inc (INSP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus
Inspire Medical Systems Reports Strong Q1 2025 Growth - TipRanks
Inspire: Q1 Earnings Snapshot - MySA
Inspire Medical Systems Q1 2025 Earnings Call Transcript - MarketBeat
Inspire Medical Systems earnings beat by $0.34, revenue topped estimates - Investing.com Canada
Earnings call transcript: Inspire Medical Systems beats Q1 2025 EPS expectations - Investing.com Nigeria
Inspire Medical Systems (INSP) Reports Strong Q1 Growth and Key Developments - GuruFocus
Inspire medical systems director Shawn McCormick sells $57,600 in stock By Investing.com - Investing.com India
Inspire medical systems director Shawn McCormick sells $57,600 in stock - Investing.com
Inspire Medical Systems Q1 2025 slides: Revenue up 23% as Inspire V launch approaches By Investing.com - Investing.com South Africa
Inspire (INSP) Updates Revenue and Earnings Guidance for FY25 | INSP Stock News - GuruFocus
Inspire Medical Systems Inc (INSP) Q1 2025 Earnings: EPS of $0.1 - GuruFocus
Inspire Medical Systems beats Q1 estimates, raises EPS outlook - Investing.com Australia
Inspire Medical Systems beats Q1 estimates, raises EPS outlook By Investing.com - Investing.com India
Inspire Medical Systems Q1 2025 slides: Revenue up 23% as Inspire V launch approaches - Investing.com
Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Inspire Medical Systems Swings to Q1 Profit, Revenue Increases; Shares Rise After Hours - marketscreener.com
Inspire Medical Systems Reports Strong Q1 2025 Revenue Growth - TipRanks
Inspire Medical Systems Swings To Profit In Q1 - Nasdaq
Inspire Medical Systems, Inc. SEC 10-Q Report - TradingView
Inspire Medical Systems Reports Strong Q1 2025 Financial ResultsNews and Statistics - IndexBox
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook - The Manila Times
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
21.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):